Key result
Higher soluble CD146 levels are linked to peripheral oedema and elevated right atrial pressure in dyspnoea.
Why the study?
The potential of soluble cluster of differentiation 146 (sCD146) to detect and grade intravascular and tissue congestion in patients presenting with acute dyspnoea required evaluation.
Does soluble CD146 concentration correlate with the degree of intravascular and tissue congestion in adult patients presenting with acute dyspnoea?
Cohort (n=437)
Yes
Does soluble CD146 concentration correlate with the degree of intravascular and tissue congestion in adult patients presenting with acute dyspnoea?
Soluble CD146 is a promising biomarker for detecting and grading peripheral venous congestion in patients with acute dyspnoea, even when NT-proBNP levels are low.
Answers are grounded in this paper and cite their sources.
May mark venous congestion in acute dyspnoea; hypothesis-generating and should not yet change practice.
OBJECTIVES: To evaluate the potential of soluble cluster of differentiation 146 (sCD146) in the detection and grading of congestion in patients with acute dyspnoea. DESIGN: Subanalysis of the prospective observational Lithuanian Echocardiography Study of Dyspnoea in Acute Settings (LEDA) cohort. SETTING: Two Lithuanian university centres. PARTICIPANTS: Adult patients with acute dyspnoea admitted to the emergency department. METHODS: Congestion was assessed using clinical and sonographic parameters. All patients underwent sCD146 and N-terminal pro-B-type natriuretic peptide (NT-proBNP) testing. RESULTS: The median value of sCD146 concentration in the study cohort (n=437) was 405 (IQR 315-509) ng/mL. sCD146 was higher in patients with peripheral oedema than in those without (median (IQR) 472 (373-535) vs 400 (304-501) ng/mL, p=0.009) and with pulmonary rales than in those without (439 (335-528) vs 394 (296-484) ng/mL, p=0.001). We found a parallel increase of estimated right atrial pressure (eRAP) and sCD146 concentration: sCD146 was 337 (300-425), 404 (290-489) and 477 (363-572) ng/mL in patients with normal, moderately elevated and high eRAP, respectively (p=0.001). In patients with low NT-proBNP, high sCD146 distinguished a subgroup with a higher prevalence of oedema as compared with patients with low levels of both biomarkers (76.0% vs 41.0%, p=0.010). Moreover, high sCD146 indicated a higher prevalence of elevated eRAP, irrespective of NT-proBNP concentration (p<0.05). CONCLUSION: sCD146 concentration reflects the degree of intravascular and tissue congestion assessed by clinical and echocardiographic indices, with this association maintained in patients with low NT-proBNP. Our data support the notion that NT-proBNP might represent heart stretch while sCD146 rather represents peripheral venous congestion.
No takes yet. Share an insight, caveat, or question.
Juknevičienė et al. (2022) conducted a cohort in Acute dyspnoea (n=437). Soluble CD146 (sCD146) vs. sCD146 below median (<405 ng/mL) or NT-proBNP was evaluated on Median sCD146 concentration (ng/mL) in patients with vs without peripheral oedema (p=0.009). Soluble CD146 levels were higher in acute dyspnoea patients with peripheral oedema and high estimated right atrial pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: